This guide has been developed to help countries implement the lateral-flow urine lipoarabinomannan assay (LF-LAM) and to incorporate this test into routine TB diagnostics algorithms. Additionally, the guide provides practical information on sample collection and storage, reading and interpretation as well as specific considerations for rolling out the test and procurement information. This guide is intended for national and subnational policymakers, front-line health workers, managers of HIV and TB programmes, and key TB stakeholders, including implementing partners.
Global Health Campus,
Chemin du Pommier 40,
1218 Le Grand-Saconnex, Geneva, Switzerland